Stronger Than Expected Q3 Performance
Cascades' Q3 2025 performance was stronger than projections, driven by improved volumes, higher average selling prices, and lower production costs. Consolidated EBITDA increased by 16% from Q2 and 14% year-over-year.
Packaging Segment Improvement
Packaging sales increased 4% sequentially, with Q3 EBITDA rising 14% sequentially to $136 million. EBITDA margins improved to 17.1% from 15.6% in Q2.
Tissue Business Growth
Third quarter sales in the Tissue segment increased 5% sequentially. EBITDA of $46 million rose 21% from Q2. Year-over-year, sales increased 6% with stronger volumes and higher average selling prices.
Net Debt Reduction
Sequentially, net debt decreased by $81 million in the third quarter, mainly due to stronger cash flow from operations and a reversal in working capital requirements.
Asset Sale and Debt Repayment
Completed sale of Flexible Packaging operation for $31 million, contributing to debt repayment. Total proceeds from asset sales amounted to $57 million this year.